Preventing cardiovascular diseases through lipid therapy modification
We adopted a systematic strategy to identify primary and secondary prevention of cardiovascular disease which resulted in enhanced lipid therapy, lifestyle advice and a 65% patient satisfaction rate.
Lakeside Healthcare Group, a multi-site GP partnership in Cambridgeshire, Lincolnshire and Northamptonshire, secured funding to review more than 1,000 at-risk patients for primary and secondary prevention of cardiovascular disease (CVD). They asked NHS Midlands and Lancashire CSU (MLCSU) to identify high-risk patients, offer lifestyle advice, and undertake remote clinical reviews to optimise their lipid therapy using NICE-approved pathways.
Our Medicines Management and Optimisation Team developed a standard operating procedure incorporating standardised review templates, structured clinical vocabulary, and treatment recommendations in line with the latest NICE pathways, guidance and evidence.
We used pathway searches to identify and risk-stratify patients – to determine the most appropriate intervention and care management based on their cardiovascular status, level of risk and priority. High-risk patients were prioritised and offered remote consultations with a pharmacist.
A patient-centred approach and shared decision-making principles resulted in patients being offered lifestyle advice, compliance advice, and/or a review of their lipid therapy. The team were keen to improve prevalence coding, and the accuracy of the information in practice registers whilst also ensuring to equip the primary care network team with the tools and processes required to continue identifying and reviewing at-risk patients.
1,311 patient reviews were completed from October 2021 to November 2022 – resulting in the optimisation of lipid therapy for 72 patients. 128 patients received lifestyle modification advice, and 15 were advised about their current lipid medications.
A patient satisfaction survey was offered to 137 patients, and 65% of respondents stated their experience with their lipid medication review was either good or very good.
Adopting a systematic strategy for identifying primary and secondary prevention CVD patients who require optimisation of lipid-modification therapy contributes significantly to reducing CVD cases. It improves population health, reduces health inequalities, and mitigates against escalating demand and costs leading to unsustainable pressures on the health and care system.
As a direct result of this project, patients were initiated on or had their lipid-modification therapy optimised as appropriate. A sustainable legacy was passed onto the local primary care network team to enable them to competently deliver lipid medication reviews going forward.
The PCN Pharmacy team will implement the learning and continue developing the service to improve patient care. We hope to work with MLCSU on future projects.
Arvind Thandi, Head of Pharmacy and Dispensary Lakeside Healthcare, Lakeside Healthcare Group
News and views
Recorded live at the NHS ConfedExpo, join host Richard Caddy in an engaging dialogue with Kelly Bishop, Assistant…
Our Health Economics Unit (HEU), in a successful collaboration with the Midlands Decision Support Network, has marked a…
The Digital Innovation Unit (DIU), along with their commercial partner Citizen Communications, are hosting an event on the 31…
How we can help health systems
Developing health systems
Acting as an independent and trusted partner within the system to facilitate working across stakeholders and integrate elements of the provider system…Learn more about Developing health systems
Workforce resilience and transformation
Supporting systems to build a sustainable and integrated workforce, transforming systems, organisations and the workforce experience to improve resilience.Learn more about Workforce resilience and transformation
Communications and engagement
Supporting ICSs with approaches to design and deliver effective communication, engagement and behavioural insights as a key enabler for system change and…Learn more about Communications and engagement
Digitally enabled transformation and IT
Digitising care and partnering with systems for the transformation of digitally enabled service delivery (and other supporting processes) across vision, planning and…Learn more about Digitally enabled transformation and IT
PHM analytics and decision support
Applying intelligence-led understanding of the health of the population to support the redesign of care and improve patient and financial outcomes across…Learn more about PHM analytics and decision support
Place and primary care transformation
Supporting providers to work together at a place and neighbourhood level to manage common resources, integrate community teams, improve health and reduce…Learn more about Place and primary care transformation
Clinical redesign and provider collaboration
Redesigning how health and care works across England - placing people at the centre of their own health and care and utilising…Learn more about Clinical redesign and provider collaboration
Personalised healthcare commissioning services
Providing end-to-end funded care services, including patients as active partners in identifying their healthcare needs and then commissioning care to meet these.…Learn more about Personalised healthcare commissioning services
Business enabling services
Delivering a wide range of support functions through transactional services, business partnering and transformation that drives efficiencies and releases value and time…Learn more about Business enabling services